Health Care/Hospital
Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combined with Ligufalimab (CD47) for First-Line Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC), Compared to Pembrolizumab
HONG KONG, Oct. 30, 2024 /PRNewswire/ -- Akeso Biopharma (9926.HK) is pleased to announce the enrollment of the first patient in its randomized, controlled, multicenter Phase III clinical study (AK117-302) for head and neck squamous cell carcinoma. This trial evaluates the innovative PD-1/VEGF bi...
RapidAI Applauded by Frost & Sullivan for Enhancing the Quality, Accuracy, and Speed of Stroke Imaging Diagnostics and Treatment, Demonstrating Its Market-leading Position
RapidAI's leadership is evident in its expansive global presence, pioneering regulatory achievements, and continuous innovation, ensuring the company remains at the forefront of AI-based imaging solutions. SAN ANTONIO, Oct. 31, 2024 /PRNewswire/ -- Recently Frost & Sullivan researched the AI-bas...
Latest Updates of Viva Biotech's Portfolio Companies
HONG KONG, Oct. 30, 2024 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the suc...
Registries using Internet Watch Foundation, Public Interest Registry protections triple in crackdown on commercial child sexual abuse gangs
New partnership provides protection from child sexual abuse material for 37,842,025 new domains in six months 'Now is the time' to act, with IWF protection available at no cost, thanks to sponsorship by Public Interest Registry. CAMBRIDGE, United Kingdom, Oct. 30, 2024 /PRNewswire/ -- A "landmar...
Telix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix®
MELBOURNE, Australia, Oct. 30, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a partnership with California-based Subtle Medical, Inc. (Subtle Medical) for artificial intelligence (AI)-powered positron emission tomography (PET) imaging with Telix...
Neurophet partners with Beijing LADO Technology… Intends to establish Joint Venture in China
* Neurophet enters into a strategic agreement with LADO to distribute Neurophet SCALE PET * Improves the efficiency of market entry with expertise of medical device go-to-market process inChina through the establishment of joint venture SEOUL, South Korea, Oct. 30, 2024 /PRNewswire/ -- Neurop...
Unleashing the Power of Red Light Therapy: Bestqool's Insights
NEW YORK, Oct. 30, 2024 /PRNewswire/ -- As society's awareness of red light therapy continues to improve, the number of people who hold a wait-and-see attitude towards red light products is also expanding. For this group of people, Bestqool, a red light product company, conducted a research surve...
I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024
- Poster to be presented in a late-breaking abstract session at the Society for Immunotherapy of Cancer (SITC) onSaturday, November 9, 2024 ROCKVILLE, Md., Oct. 30, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company exclusively focused on the develop...
World Stroke Congress | TASTE-2 significantly reduces stroke disability
NANJING, China, Oct. 30, 2024 /PRNewswire/ -- Oct 24th 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that a new clinical study with major clinical findings regarding Sanbexin (edaravone and dexborneol concentrated solution for injection) has been published at the 16th World Stroke...
Teijin and Hilleman Laboratories to Expand Business in Asia-Pacific via Strategic Partnership to Promote CDMO Services in Cell and Gene Therapy
SINGAPORE, Oct. 30, 2024 /PRNewswire/ -- Teijin Limited
Ban Ki-moon Calls for Global Unity in Pursuit of Sustainable Development at 2024 ESG Global Leaders Conference
SHANGHAI, Oct. 30, 2024 /PRNewswire/ -- The 2024 ESG Global Leaders Conference was held inShanghai from October 16th to 18th. Ban Ki-moon, Former Secretary-General of the United Nations, Chairman of the Boao Forum forAsia, attended and delivered a closing remarks. The 2024 ESG Global Leaders Con...
Pulsenmore Expands Partnership with Clalit Health Services to Deliver 25,000 Home Ultrasound Devices for Remote Prenatal Care
RAMAT GAN, Israel, Oct. 30, 2024 /PRNewswire/ -- Pulsenmore (TASE: PULS), a pioneering provider of home-based ultrasound technology, has announced the renewal and expansion of its strategic partnership with Clalit Health Services, Israel's largest HMO. Over the next five years, Pulsenmore will sup...
Philips Massager Singapore Marks a Milestone as Support Sponsor at Garmin Run Singapore 2024
SINGAPORE, Oct. 30, 2024 /PRNewswire/ -- Philips Massager, a new category within the Royal Philips group, proudly participated as the support sponsor for the Garmin Run Singapore 2024, which took place onOctober 13 at the scenic Marina Barrage. This collaboration marked a significant milestone fo...
Fosun Pharma Announces 2024Q3 Financial Results
Revenue Exceed RMB30.9 Billion with R&D Expenditure RMB3.9 Billion Continuing to Consolidate its Dominant Position In The fields of Breast Cancer and Lung Cancer SHANGHAI, Oct. 29, 2024 /PRNewswire/ -- On October 29, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group";...
Hot from Hong Kong Fintech Week 2024: AI's Role in Transforming Insurance
SINGAPORE, Oct. 30, 2024 /PRNewswire/ -- At the 2024 Hong Kong FinTech Week InsurTech Forum,Charles Hung, CEO of Blue Insurance; Gilbert Leung, CEO of Novo AI; andPriscilla Ng, Prudential's Group Chief Customer & Marketing Officer explored the transformative role of AI in the insurance sector. Th...
WuXi AppTec Named Global CRDMO Company of the Year by Frost & Sullivan for the Eighth Consecutive Year
SHANGHAI, Oct. 29, 2024 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, has been awarded the 2024 Global CRDMO Company of the Year Award by Frost & Sullivan, a gr...
Celltrion presents post hoc analysis of LIBERTY studies of ZYMFENTRA® (infliximab-dyyb) at the American College of Gastroenterology 2024 Annual Scientific Meeting
* Pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC) previously demonstrated superior efficacy of subcutaneous (SC) infliximab over placebo for maintenance therapy in patients with Crohn's disease (CD) and ulcerative colitis (UC)[1], [2] * ZYMFENTRA® is the first and only FDA-approved subcut...
I Peace announces new iPSC lines to reduce immune rejection risk for U.S. population
More than 100 million people in the US have this HLA-A haplotype
PALO ALTO, Calif., Oct. 29, 2024 /PRNewswire/ -- Leading GMP cell CDMO I
Peace, Inc. (https://www.ipeace.com
LILYSILK Continues Partnership with National Breast Cancer Foundation for Breast Cancer Awareness Month
NEW YORK, Oct. 29, 2024 /PRNewswire/ -- LILYSILK
DeepQure Presents Clinical Results of Laparoscopic RDN at TCT 2024, Demonstrating Cutting-edge Technology and Innovation
SEOUL, South Korea, Oct. 29, 2024 /PRNewswire/ -- DeepQure, a global pioneer in resistant hypertension treatment, has unveiled clinical results of its laparoscopic renal denervation (RDN) medical device "HyperQure". Designed to treat resistant hypertension,HyperQure uses a laparoscopic approach t...
Week's Top Stories
Most Reposted
Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery
[Picked up by 323 media titles]
2025-01-13 09:05URBAN REVIVO Celebrates Lunar New Year with Unique Collaboration with Artist Mercedes Bellido
[Picked up by 294 media titles]
2025-01-13 10:44RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
[Picked up by 294 media titles]
2025-01-14 21:00Gen Z Travelers Drive Buy Now, Plan Later Travel Bookings by Over 20%: Fliggy's 2024 Buy Now Plan Later Travel Insight
[Picked up by 286 media titles]
2025-01-10 16:04LANDI Global Unveils Flagship Cx20: Elevating business efficiency and customer experience with a next-generation Windows-powered terminal
[Picked up by 274 media titles]
2025-01-11 22:30